|  | Omeprazole | Famotidine | Mosapride | Teprenone | ||||
---|---|---|---|---|---|---|---|---|---|
 |  | n | Proportion with sufficient overall symptom relief | n | Proportion with sufficient overall symptom relief | n | Proportion with sufficient overall symptom relief | n | Proportion with sufficient overall symptom relief |
Symptom severity * | Moderate | 104 | 72.1% | 96 | 44.8% | 91 | 38.5% | 47 | 29.8% |
Severe | 29 | 48.3% | 26 | 26.9% | 22 | 27.3% | 18 | 38.9% | |
Number of symptoms | ≤ 4 | 28 | 78.6% | 36 | 55.6% | 23 | 43.5% | 14 | 64.3% |
≥ 5 | 105 | 63.8% | 86 | 34.9% | 90 | 34.4% | 51 | 23.5% | |
Predominant symptom type †| GERD | 56 | 76.8% | 36 | 22.2% | 35 | 45.7% | 21 | 23.8% |
Dyspepsia | 95 | 68.4% | 93 | 47.3% | 77 | 40.3% | 51 | 33.3% | |
Other | 59 | 62.7% | 46 | 34.8% | 55 | 30.9% | 30 | 26.7% |